Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

15 Oct 2014 07:30

RNS Number : 3213U
Sinclair IS Pharma PLC
15 October 2014
 



15 October 2014

Directors' Dealings

 

Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Group") the international specialty pharma company, was informed on 14 October 2014 that earlier that day Julie Spooner, spouse of Chris Spooner, the Chief Executive Officer, acquired 238,430 ordinary shares in Sinclair. The purchases were made at an average price of 26.25p per share. Following this purchase Chris Spooner has a beneficial interest in 8,989,164 ordinary shares representing 1.81% of the Group's issued ordinary share capital. 

Sinclair was also informed on 14 October 2014 that earlier that day Christophe Foucher, the Chief Operating Officer, acquired 35,000 ordinary shares in Sinclair at an average price of 24.25p per share. Following this purchase Christophe Foucher has a beneficial interest in 191,200 ordinary shares representing 0.04% of the Group's issued ordinary share capital.

For further information, please contact:

Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

 

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Clare Terlouw

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIAIILSLIS

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS